Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management
Ken Shirabe(Gunma University), Yoshihiko Maehara(Kyushu University), Hideaki Uchiyama(Kyushu University), Tomoharu Yoshizumi(Kyushu University), Yohei Mano(National Center for Global Health and Medicine), Rumi Matono(Kyushu University), Kazuki Takeishi(University of Pittsburgh), Takeo Toshima(Kyushu University Hospital), Hideki Ijichi(Kyushu University), Akinobu Taketomi(Hokkaido University), Takashi Motomura(Kyushu University), Noboru Harada(Kyushu University), Jun Muto(Fujita Health University)
Cited by 69
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244